Blog

Giuseppe Minniti: We desperately need a new meningioma classification to better select patients who need adjuvant stereotactic radiosurgery/stereotactic radiation therapy

Photo of Giuseppe Minniti from ao-siena.toscana.it

Aug 13, 2023, 19:09

Giuseppe Minniti: We desperately need a new meningioma classification to better select patients who need adjuvant stereotactic radiosurgery/stereotactic radiation therapy

Quoting Giuseppe Minniti, Chair of the Academic Unit of Radiation Oncology in the Department of Medicine, Surgery, and Neuroscience at the University of Siena:

“We desperately need a new meningioma classification to better select patients who need adjuvant stereotactic radiosurgery/stereotactic radiation therapy. Waiting for EORTC meningioma committee trials and studies and presentations at EANO meeting in Rotterdam 2023.”

Source: Giuseppe Minniti / Twitter

cancer EORTC Giuseppe Minniti meningioma OncoDaily Oncology radiation oncology Rotterdam stereotactic radiation therapy stereotactic radiosurgery University of Siena

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity